Nexstim - Aivostimulaatiolla maailmanvalloitukseen

Tuon Sinaptican mahdollisuuden kokoa on kyllä hankala hahmottaa. Se on kokoluokassaan niin järjettömän iso verrattuna Nexstimin nykyiseen bisnekseen. Täytyy vaan pitää peukkuja että saavat FDA-luvan, niin sitten on kyllä leveä latu auki sekä Nexstimille että Sinapticalle.

  • Over 55 million people worldwide are living with dementia, with numbers expected to triple by 2050 due to aging populations.
  • Nearly 10 million new cases of dementia are diagnosed each year.
  • Age-Related Risk – Dementia primarily affects older adults, with prevalence increasing significantly after 65 years of age.
  • Alzheimer’s disease is the most common type of dementia, accounting for 60-80% of cases.
  • Women are at a higher risk than men, likely due to longer life expectancy and hormonal factors.
  • High-income countries have higher reported prevalence, but cases are rising rapidly in low- and middle-income countries (LMICs) due to aging populations and limited healthcare access.
  • Family history, cardiovascular diseases, diabetes, and unhealthy lifestyles (smoking, poor diet, lack of exercise) contribute to dementia risk.
  • Dementia-related costs are projected to exceed $1.3 trillion annually, placing a heavy burden on healthcare systems and caregivers.
  • Mortality Rate – Dementia is a leading cause of death, ranking among the top five causes of mortality in many developed nations.
  • Though rare, dementia can occur before 65 years of age, accounting for about 5-10% of all cases.
19 tykkäystä